ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Safety of Antithymocyte Globulin Use in Donation after Circulatory Death (DCD) Liver Transplantation

    D. Felix,1 B. Geiger,1 J. Descourouez,1 M. Jorgenson,1 B. Hanlon,2 G. Leverson,2 D. Foley.2

    1Department of Pharmacy, UW Health, Madison, WI; 2Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI.

    Purpose: Rabbit antithymocyte globulin (rATG) is commonly used for induction immunosuppression and treatment of rejection in solid organ transplantation. Previous work has shown that rATG…
  • 2018 American Transplant Congress

    Prospective Trial Using Pulmonary Rehabilitation to Treat Frailty

    C. Kennedy,1 P. Novotny,2 E. Stevens,1 J. Kirsch,3 J. Garrett,1 N. LeBrasseur,4 R. Benzo.1

    1Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN; 2Health Sciences Research, Mayo Clinic, Rochester, MN; 3Clinical and Health Psychology, University of FL, Gainesville, FL; 4Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN.

    Background: Frailty is a novel risk factor to potential lung transplant candidates and recipients associated with excess morbidity and mortality. Limited data is available on…
  • 2018 American Transplant Congress

    Th17 and NK Responses Are Differentially Induced in Renal Allografts According to Recipient Murine Cytomegalovirus Dose and Strain

    M. Shimamura,1 M. Li,2 S. Boddeda,1 B. Chen,2 Q. Zeng,1 T. Schoeb,2 V. Velazquez.1

    1Center for Vaccines and Immunity and Dept. of Pediatric Infectious Diseases, The Research Institute at Nationwide Children's Hospital and The Ohio State University, Columbus, OH; 2Depts. of Pediatric Infectious Diseases, Pathology, and Genetics, University of Alabama at Birmingham, Birmingham, AL.

    Purpose: To study the impact of cytomegalovirus (CMV) recipient positive (R+) serostatus upon renal allograft injury, murine CMV (MCMV) D+/R+ kidney transplants using recipients infected…
  • 2018 American Transplant Congress

    The Benefit of Higher KDPI Renal Transplantation over Waiting for a Better Offer

    E. Grodstein,1 J. Yang,2 V. Nair,1 E. Molmenti,1 L. Teperman.1

    1Transplant Institute, Northwell Health, Manhasset, NY; 2Department of Epidemiology, Northwell Health, Manhasset, NY.

    Background: The kidney donor profile index (KDPI) helps discern kidney function. While recipients must consent for KDPI >85% kidneys, clinicians often decide whether to accept…
  • 2018 American Transplant Congress

    Prevalence of Frailty among Kidney Transplant Recipients in the United States

    A. Thomas,1 A. Shaffer,1 H. Ying,1 S. Norman,2 D. Segev,1 M. McAdams-DeMarco.1

    1JHU, Baltimore; 2University of Michigan, Ann Arbor.

    Frailty, a measure of physiologic reserve, increases the risk of delayed graft function, longer length of stay, early hospital readmission, immunosuppression intolerance, and mortality among…
  • 2018 American Transplant Congress

    Delayed Graft Function in Simultaneous Liver Kidney Transplantation

    S. Weeks,1 X. Luo,1 S. Ottmann,1 A. Gurakar,2 F. Naqvi,2 B. Philosophe,1 A. Cameron,1 N. Desai,1 D. Segev,1 J. Garonzik Wang.1

    1Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD; 2Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD.

    Purpose: Increased rates of delayed graft function (DGF) after simultaneous liver kidney (SLK) transplantation have been described, as well as inferior graft survival in patients…
  • 2018 American Transplant Congress

    Approaches to Prevention of Antibody Rebound after HLA Sensitization in a Mouse Model

    I. Kim, G. Wu, N-.N. Chai, A. Klein, S. Jordan.

    Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.

    Purpose: Control of donor specific antibodies (DSA) is critical for prevention of antibody mediated rejection (ABMR). Removal of DSAs with PLEX often results in significant…
  • 2018 American Transplant Congress

    Prevention and Reversal of Diabetes through Restoration of B and T Cell Regulation and Immune Homeostasis

    K. Brayman,1 P. Chhabra,1 C. Wilson,2 A. Marshall,2 D. Moore.2

    1Surgery, University of Virginia, Charlottesville, VA; 2Pediatric Endocrinology, Vanderbilt University, Nashville, TN.

    Goal: To determine the mechanisms by which IgM restores immune homeostasis in new-onset diabetic NOD mice.Methods: 1) 5wks old non-obese diabetic (NOD) mice received mouse…
  • 2018 American Transplant Congress

    Circulating Exosomes with Lung Self-Antigens, Kα1Tubulin and Collagen V, and Immune Regulatory Proteins in Lung Transplant Recipient with Primary Graft Dysfunction

    M. Sharma, S. Biswas Roy, R. Walia, A. Omar, R. Bremner, M. Smith, T. Mohanakumar.

    Norton Thoracic Institute, St. Joseph's Hospital & Medical Center, Phoenix.

    Background: Circulating exosomes isolated from lung transplant recipients (LTxRs) with acute or chronic rejection contains lung self-antigens (SAgs), K alpha 1 tubulin (Kα1T) and collagen…
  • 2018 American Transplant Congress

    Treatment of Active Chronic Antibody-Mediated Rejection with Rituximab, IVIG and Plasma Exchange

    G. Piñeiro,1 J. Rovira,2 E. De Sousa-Amorim,1 J. Villarreal,1 M. Sole,3 I. Revuelta,1 M. Lozano,4 E. Palou,4 F. Oppenheimer,1 J. Campistol,1 F. Diekmann.1,2

    1Nephrology and Renal Transplantation, Hospital Clinic de Barcelona, Barcelona, Spain; 2Laboratori Experimental de Nefrologia i Trasplantament (LENIT), Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; 3Pathology, Hospital Clinic de Barcelona, Barcelona, Spain; 4Apheresis Unit, Hemotherapy and Hemostasis, Hospital Clinic de Barcelona, Barcelona, Spain; 5Immunology, Hospital Clinic de Barcelona, Barcelona, Spain.

    Chronic antibody-mediated rejection (cABMR) and transplant glomerulopathy (TG) are main features associated with long-term graft loss. Despite its clinical significance, the available evidence on treatment…
  • 1
  • 2
  • 3
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences